Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

What does it take to open a restaurant on Franklin Street?
Kenan-Flagler Business School professor Dr. Ted Zoller said restaurant culture in Chapel Hill manifests in the East Franklin Street and West Franklin Street markets, which...
Wed Dec 3, 2025

UNC professor Kathleen DuVal shares expertise in Ken Burns documentary ‘The American Revolution’
Kathleen DuVal’s American Revolution course at UNC enrolls around 150 students, but last week she shared history lessons with a few additional people — millions...
Wed Dec 3, 2025

'Epitomized the Carolina Spirit': UNC remembers Eve Carson on her 40th birthday
Eve Carson, former student body president and Morehead-Cain scholar, was killed during the spring semester of her senior year at UNC. In 2007, as a...
Sat Nov 29, 2025

New ESPN documentary to highlight Stuart Scott’s life, legacy
The phrase “boo-yah” did not enter the lexicon without resistance. At a time when the sports broadcasting vernacular was bound by the constraints of Merriam...
Fri Nov 28, 2025